IFNA2 and metastatic melanoma: The second study demonstrated an impact of the cytokine unresponsiveness by determination of HLA class I antigen expression levels on metastatic melanoma lesions during the course of the disease in one patient undergoing IFN-α2b and autologous vaccination plus BCG (MVAX).